Absorption of different oral dosage forms of oxycodone in the elderly: A cross-over clinical trial in patients undergoing cystoscopy

European Journal of Clinical Pharmacology

Volumn 68, Issue 10, 2012, Pages 1357-1363

  Kokki, Merja ^a,b   Välitalo, Pyry ^b   Rasanen, Ilpo ^c   Sirpa Aaltomaa, ^a   Ojanperä, Ilkka ^c   Matti Eskelinen, ^a   Kokki, Hannu ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Drug administration routes; Elderly; Intravenous administration; Oral administration; Oxycodone; Pharmacokinetics

Indexed keywords

OXYCODONE;

AGED; ARTICLE; BLEEDING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTOSCOPY; DISTRIBUTION VOLUME; DIZZINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CLEARANCE; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; FATIGUE; FEMALE; HEADACHE; HUMAN; LEG PAIN; MALE; NAUSEA; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWEATING; TACHYPNEA; URINARY URGENCY; VISUAL DISORDER; VOMITING;

ABSORPTION; ADMINISTRATION, ORAL; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; CYSTOSCOPY; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; OXYCODONE;

EID: 84866633491     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1267-9     Document Type: Article

References (22)

1. Kalso E (2005) Oxycodone. J Pain Symptom Manage 29:47S-56S
2. Kokki H, Rasanen I, Reinikainen M, Suhonen P, Vanamo K, Ojanperä I (2004) Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin Pharmacokinet 43:613-622
3. Cusack B (2004) Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2:274-302
4. Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT (2011) Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups. Drug Aging 28:41-50
5. Aubrun F, Marmion F (2007) The elderly patient and postoperative pain treatment. Best Pract Res Clin Anaesthesiol 21:109-127
6. McLean AJ, Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56:163-184
7. Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosboøl EL et al (2009) Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 169:141-149
8. Turnheim K (2005) Pharmacokinetic dosage guidelines for elderly subjects. Expert Opin Drug Metab Toxicol 1:33-48
9. Kaestli LZ, Wasilewski-Rasca AF, Bonnabry P, Vogt-Ferrier N (2008) Use of transdermal drug formulations in the elderly. Drugs Aging 25:269-280
10. Fleisher LA (2010) Risk of anesthesia. In: Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL (eds) Miller's anesthesia, 7th edn. Elsevier, Philadelphia, pp 969-999
11. Kokki H, Rasanen I, Laisalmi M, Lehtola S, Ranta VP, Vanamo K, Ojanperä I (2006) Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. Clin Pharmacokinet 45:745-754
12. Jonsson EN, Karlsson MO (1999) Xpose-an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58:51-64
13. Mandema JW, Kaiko RF, Oshlack B, Reder RF, Stanski DR (1996) Characterization and validation of a pharmacokinetic model for controlled-release oxycodone. Br J Clin Pharmacol 42:747-756
14. Beal SL (2001) Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 28:481-504
15. Nieminen TH, Hagelberg NM, Saari TI, Pertovaara A, Neuvonen M, Laine K, Neuvonen PJ, Olkkola KT (2009) Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone. Anesthesiology 110:1371-1378
16. Leow KP, Smith MT, Williams B, Cramond T (1992) Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin Pharmacol Ther 52:487-495
17. Pöyhiä R, Olkkola KT, Seppälä T, Kalso E (1991) The pharmacokinetics of oxycodone after intravenous injection in adults. Br J Clin Pharmacol 32:516-518
18. Takala A, Kaasalainen V, Seppälä T, Kalso E, Olkkola KT (1997) Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone. Acta Anaesthesiol Scand 41:309-312
19. Leow KP, Cramond T, Smith MT (1995) Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesth Analg 80:296-302
20. Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M, Neuvonen PJ, Olkkola KT (2008) Plasma concentrations of oral oxycodone are greatly increased in the elderly. Clin Pharmacol Ther 84:462-467
21. Villesen HH, Banning AM, Petersen RH, Weinelt S, Poulsen JB, Hansen SH, Christrup LL (2007) Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Ther Clin Risk Manag 3:961-967
22. Zimmer AW, Calkins E, Hadley E, Ostfeld AM, Kaye JM, Kaye D (1985) Conducting clinical research in geriatric populations. Ann Intern Med 103:276-283